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ABSTRACT
Objective: To evaluate whether intrapartum cardiotocography with computer analysis decreases
the incidence of newborn metabolic acidosis or obstetric intervention when compared with vis-
ual analysis through a systematic review with meta-analysis of randomized controlled trials.
Methods: The research was conducted using Medline, Embase, Web of Science, Scopus,
ClinicalTrial.gov, Ovid and Cochrane Library as electronic databases from the inception of each
database to May 2018. Selection criteria included randomized trial evaluating women with ceph-
alic presentation at term or late preterm term during labor who were randomized to electronic
fetal heart rate monitoring with either computer analysis (i.e. intervention group) or standard
visual analysis (i.e. control group). Trials evaluating antenatal fetal heart rate monitoring in
women not in labor were excluded. The primary outcome was incidence of newborn metabolic
acidosis, defined as pH less than 7.05 and base deficit greater than 12mmol/L. Secondary out-
comes were mode of delivery, admission to neonatal intensive care unit, hypoxic–ischemic
encephalopathy, and perinatal death. The summary measures were reported as relative risk (RR)
with 95% confidence interval (CI).
Results: Three randomized controlled trials (RCTs), including 54,492 participants, which met
inclusion criteria for this meta-analysis, were analyzed. All the included trials enrolled women
with cephalic presentation at term or late preterm. Women were randomized in the active first
stage of labor and all of them received continuous cardiotocography (CTG) from randomization
until delivery. Women who received continuous CTG during labor with computerized analysis
had similar risk of newborn metabolic acidosis. No between group differences were found in
the secondary outcomes.
Conclusions: Compared with visual analysis, use of computer analysis of fetal monitoring signals
during labor did not significantly reduce the rate of metabolic acidosis or obstetric intervention.
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Key message
Compared with visual analysis, computer analysis of
fetal monitoring signals did not significantly
reduce the rate of metabolic acidosis or obstetric
intervention.
Introduction
Electronic fetal hear rate monitoring (EFM), or cardio-
tocography (CTG), records changes in fetal heart rate
and their temporal relationship to uterine contraction.
It has been developed with the aim of detecting fetal
hypoxia during labor and hence to prevent metabolic
acidosis. Despite being the standard for intrapartum
management [1], this technique, significantly increase
the operative delivery rate, and is associated only with
less seizures as neonatal benefit [2]. Another concern
is also the variability in the interpretation.
Several techniques have been studied in order to
decrease the high false positive rate. Fetal ST
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waveform analysis (STAN) has been studied combined
with CTG. A recent meta-analysis of randomized trials,
however, showed that STAN during labor did not
improve perinatal outcomes or decrease operative
delivery rates, except for a 9% decrease in operative
vaginal delivery [3,4]. Comparisons of visual and com-
puterized interpretation of EFM have also been
reported. However, whether or fetal monitoring with
computer analysis improve perinatal outcomes is still
subject of debate.
Thus, we aim to evaluate whether intrapartum fetal
monitoring with computer analysis decreases the inci-
dence of newborn metabolic acidosis or obstetric
intervention when compared with visual analysis
through a systematic review with meta-analysis of
randomized controlled trials (RCTs).
Materials and methods
Search strategy
This review was performed according to a protocol
designed a priori and recommended for systematic
review [5]. Electronic databases (i.e. Medline, Scopus,
ClinicalTrials.gov, Embase, ScienceDirect, the Cochrane
Library at the CENTRAL Register of Controlled Trials,
Scielo) were searched from their inception until May
2018. Search terms used were the following text
words: cardiotocography, electronic fetal heart moni-
toring, quantitative, expert system, fetal assessment,
labor, and labor. No restrictions for language or geo-
graphic location were applied. In addition, the refer-
ence lists of all identified articles were examined to
identify studies not captured by electronic searches.
The electronic search and the eligibility of the studies
were independently assessed by two authors (G. S.
and S. T.). Differences were discussed and consen-
sus reached.
Selection criteria
Selection criteria included RCTs evaluating women
with singleton or multiple gestations and cephalic
presentation at term or late preterm during labor who
were randomized to electronic fetal heart rate moni-
toring with either computer analysis (i.e. intervention
group) or standard visual analysis (i.e. control group).
Trials evaluating antenatal fetal heart rate monitoring
in women not in labor were excluded. Quasi-random-
ized trials (i.e. trials in which allocation was done on
the basis of a pseudorandom sequence, e.g. odd/even
hospital number or date of birth, alternation) were
also excluded.
Data extraction and risk of bias assessment
The risk of bias in each included study was assessed
by using the criteria outlined in the Cochrane
Handbook for Systematic Reviews of Interventions.
Seven domains related to risk of bias were assessed in
each included trial since there is evidence that these
issues are associated with biased estimates of treat-
ment effect: (1) random sequence generation; (2) allo-
cation concealment; (3) blinding of participants
and personnel; (4) blinding of outcome assessment;
(5) incomplete outcome data; (6) selective reporting;
and (7) other bias. Review authors’ judgments were
categorized as “low risk,” “high risk,” or “unclear risk”
of bias [5].
Two authors (G.S. and S. T.) independently assessed
inclusion criteria, risk of bias and data extraction.
Disagreements were resolved by discussion.
All analyses were done using an intention-to-treat
approach, evaluating women according to the treat-
ment group to which they were randomly allocated in
the original trials. Primary and secondary outcomes
were defined before data extraction.
The primary outcome was incidence of newborn
metabolic acidosis, defined as pH less than 7.05 and
base deficit greater than 12mmol/L. Secondary out-
comes were mode of delivery, admission to neonatal
intensive care unit, hypoxic–ischemic encephalopathy,
and perinatal death.
Statistical analysis
The data analysis was completed independently by
two authors (G. S. and S. T.) using Review Manager v.
5.3 (The Nordic Cochrane Centre, Cochrane
Collaboration, 2014, Copenhagen, Denmark). The com-
pleted analyses were then compared, and any differ-
ence was resolved by discussion. The summary
measures were reported as summary relative risk (RR)
with 95% of confidence interval (CI) using the random
effects model of DerSimonian and Laird. I-squared
(Higgins I2) greater than 0% was used to identify het-
erogeneity. Data from each eligible study were
extracted without modification of original data onto
custom-made data collection forms. A 2 by 2 table
was assessed for RR. Data were extracted and
imported into Review Manager v. 5.3 (The Nordic
Cochrane Centre, Cochrane Collaboration, 2014,
Copenhagen, Denmark).
Potential publication biases were assessed statistic-
ally by using Begg’s and Egger’s tests. p Value < .05
was considered statistically significant. The meta-ana-
lysis was reported following the Preferred Reporting
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Item for Systematic Reviews and Meta-analyses
(PRISMA) statement [6].
Results
Study selection and study characteristics
Three RCTs, including 54,492 participants [7–9], which
met inclusion criteria for this meta-analysis, were ana-
lyzed (Figure 1). The overall risk of bias was judged as
low. Most studies had a low risk of bias in selective
reporting and incomplete outcome data according with
the Cochrane Collaboration’s tool. No study was double
blind because this was deemed difficult methodologic-
ally given the intervention (Figure 2). Statistically
heterogeneity within the trials ranged from low to high
with and I2 ¼ 74% for the primary outcome. Publication
bias, assessed using Begg’s and Egger’s tests, was not
significant (p ¼ .84 and .80, respectively).
The characteristics of the three included trials are
summarized in Table 1. All the included trials enrolled
women with cephalic presentation at term or late pre-
term. Two studies included only singleton gestations,
while one study included both singletons and twins.
Women were randomized in the active first stage of
labor and all of them received continuous CTG from
randomization until delivery. Two trials had newborn
metabolic acidosis, defined as pH less than 7.05 and
base deficit greater than 12mmol/L, as primary out-
come [7, 8], while the INFANT trial [9] had a composite
of perinatal outcome as primary outcome.
Synthesis of results
Women who received continuous CTG during labor
with computerized analysis had similar risk of new-
born metabolic acidosis (RR¼ 0.72, 95% CI¼ 0.37–1.40;
Figure 3). No between group differences were found
in the secondary outcomes, including mode of deliv-
ery, admission to neonatal intensive care unit, hypoxi-
c–ischemic encephalopathy, and perinatal death
(Table 2).
Discussion
Principal findings
This meta-analysis of pooled data from three RCTs
showed that intrapartum fetal monitoring with com-
puter analysis did not decrease the incidence of new-
born metabolic acidosis or obstetric intervention when
compared with visual analysis.
Our meta-analysis represented level-1 data and
included appropriately powered, large-scale, multicen-
ter, well-designed RCTs. Test of heterogeneity points
to the non-efficacy of computerized CTG as studied so
far. This may be the first meta-analysis analyzing the
efficacy of computerized analysis of CTG during labor.
Limitations of our study are inherent to the limitations
of the included RCTs. Only three trials were included,
and none of them were double-blind. The three
included trials had different inclusion criteria, and
used different system for CTG analysis. The vast major-
ity of the included women came from one large trial
[9], which therefore drives the statistics.
Notably, the RCTs did not validate the clinical use
aspect fully. Studies should be complemented with
observational studies conducted over much longer
Figure 1. Flow diagram of studies identified in the systematic
review. (Prisma template [Preferred Reporting Item for
Systematic Reviews and Meta-analyses]).
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periods that were more consistent with standard
obstetric practice. Another issue is the complementary
technology of education and coherent management
of the CTG based information that is included in both
arms of a study. In this type of study, there is also the
need to analyze the attitude towards a new technol-
ogy and the ability to follow clinical guidelines.
Another shortcoming is the lack of definition of
method of calculating base deficit for cord metabolic
acidosis. The very low incidence of metabolic acidosis,
moreover, limits the power of the analysis.
Interpretation
Different techniques have been studied to improve
delivery outcomes of pregnant women [10–20]. Given
the limitations of the standard CTG, authors focused
on alternatives which could decrease the false positive
rate of EFM [3,4]. In 1977, Dawes and Redman at
Oxford University in UK, started to investigate the
association between outcomes and numerical analysis
of the fetal heart rate parameters, in pregnancy.
Dawes and Redman were able to quantifying parame-
ters that are difficult to assess by the human eye, such
as short- and long-term variability. Specifically they
demonstrated that the short-term variability (STV), par-
ameter that is very closed to the beat to beat vari-
ation, correlates well with the development of
metabolic acidemia and intrauterine death. The system
is today named Sonicaid FetalCare, and is based on a
database with more than 73,500 traces [21]. The com-
puterized CTG represent a more objective method for
the analysis of the fetal heart rate than the visual CTG
in pregnancy [22]. Such methodic has been introduced
to overcoming the problems related to the analysis
and interpretation of the cardiotocographic traces
Figure 2. Assessment of risk of bias. (A) Summary of risk of bias for each trial; Plus sign: low risk of bias; minus sign: high risk of
bias; question mark: unclear risk of bias. (B) Risk of bias graph about each risk of bias item presented as percentages across all
included studies.
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during pregnancy, the so-called “Non stress test,” sub-
jected to inter- and intraoperator variability, and to
identify fetuses at risk of fetal acidosis. Computerized
CTG, based mostly on Dawes/Redman criteria, is now
the standard non-stress test for antepartum manage-
ment of high-risk pregnancies, including those compli-
cated by intrauterine fetal growth restriction, in
Europe [23,24].
After the development of the Sonicaid system, others
computerized systems, where developed in order to
overcome the poor reproducibility of visual analysis [25].
SisPort, for example, is a program for automated ana-
lysis of tracing during labor developed at the University
of Porto by Ayres-de-Campos [26], to perform the auto-
mated analysis of cardiotocograms. Nexius and INFANT
(K2 Medical System) are the two decision support
software used respectively in the trials by Nunes [8] and
in the Infant trial [9]. Both centralizes viewing of fetal
signals during labor, allowing simultaneous monitoring
of multiple tracings in one or more locations. Both dis-
play the cardiotocograph on a computer screen along-
side other clinical data collected as part of routine of
clinical care.While, computerized CTG has been proven
to improve perinatal outcomes when used antepartum
as nonstress test in high-risk pregnancies [23,24], the
efficacy during labor, is still subject of debate [27]. This
review with meta-analysis showed that, when used in
laboring women, in clinical trials, compared with visual
analysis, computer analysis of fetal monitoring signals
that do not include the new guidelines interpretation of
CTG, did not significantly reduce the rate of metabolic
acidosis or obstetric intervention.
Table 1. Characteristics of the included studies.
Ignatov 2016 [7] Nunes 2017 [8] INFANT trial 2017 [9]
Study location Bulgaria UK UK and Ireland
Number of centers 1 5 24
Number of patients
includeda
720 (360 versus 360) 7730 (3961 versus 3769) 46,042 (22,987 versus 23,055)
Inclusion criteria Maternal age >18 y/o;
singleton pregnancy,
vertex presentation
>36 weeks; no major
fetal malformation; active
first stage of labor; con-
tinuous EFMMaternal age
16 y/o; singleton preg-
nancy, vertex presentation
>36 weeks; no major fetal
malformation; active first
stage of labor; continu-
ous EFM
Maternal age 16 y/o; singleton or twin pregnancy,
vertex presentation >35 weeks;
no major fetal malformation; active first stage
of labor; continuous EFM
Computerized system used NEXUS/OBSTETRICS system
(Nexus GMT, Frankfurt,
Germany)
Omniview-SisPorto program Infant system
Characteristics of the
computerized analysis
Microfluctuations analysis in
fetal heart rate (OSZ),
fetal 48 heart rate (FRQ)
and DEC scored on a
scale ranging between
0 (normal measure) and
6 (highly abnormal meas-
ure) and summated for an
overall CTG score
Analysis of fetal heart rate and toco combined
with electrocardiographic ST analysis, where available
Analysis of fetal heart signals:
baseline heart rate; heart-
rate variability; accelera-
tions and type and timing
of decelerations; quality of
the signal; and contrac-
tion pattern
aData are presented as total number (number in the intervention group versus number in the control group).
DEC: decelerations; CTG: cardiotocography; EFM: electronic fetal monitoring.
Figure 3. Forest plot for the risk of newborn metabolic acidosis, defined as pH less than 7.05 and base deficit greater than
12mmol/L.
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Conclusions
In summary, compared with visual analysis, use of
computer analysis of fetal monitoring signals during
labor at term or late preterm did not significantly
reduce the rate of metabolic acidosis or obstetric
intervention.
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